MD HB664 | 2020 | Regular Session

Status

Sponsorship: Committee Bill
Status: Introduced on January 29 2020 - 25% progression, died in committee
Action: 2020-01-30 - Hearing 2/25 at 1:00 p.m.
Pending: House Health and Government Operations Committee
Text: Latest bill text (Introduced) [PDF]

Summary

Requiring a pharmacist or a pharmacist's designee who is under certain supervision to inform a certain consumer of the availability of certain therapeutically equivalent drugs, substantially equivalent medical devices, or interchangeable biological products and the cost difference between those drugs, devices, or products and certain prescribed drugs, medical devices, or biological products; etc.

Tracking Information

Register now for our free OneVote public service or GAITS Pro trial account and you can begin tracking this and other legislation, all driven by the real-time data of the LegiScan API. Providing tools allowing you to research pending legislation, stay informed with email alerts, content feeds, and share dynamic reports. Use our new PolitiCorps to join with friends and collegaues to monitor & discuss bills through the process.

Monitor Legislation or view this same bill number from multiple sessions or take advantage of our national legislative search.

Title

Pharmacists - Required Notification and Authorized Substitution - Lower-Costing Drugs, Medical Devices, and Biological Products

Sponsors


History

DateChamberAction
2020-01-30HouseHearing 2/25 at 1:00 p.m.
2020-01-29HouseFirst Reading Health and Government Operations

Subjects


Code Citations

ChapterArticleSectionCitation TypeStatute Text
Health Occupations12101(n/a)See Bill Text
Health Occupations12504(n/a)See Bill Text

Maryland State Sources


feedback